相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma
Mariano Russo et al.
CANCER (2020)
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
Alicia Leon-Castillo et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
SOX17 Inhibits Tumor Metastasis Via Wnt Signaling In Endometrial Cancer
Weiqiang Zhou et al.
ONCOTARGETS AND THERAPY (2019)
Clinical actionability of molecular targets in endometrial cancer
Mary Ellen Urick et al.
NATURE REVIEWS CANCER (2019)
The NCl-MATCH trial and precision medicine in gynecologic cancers
Lisa Barroilhet et al.
GYNECOLOGIC ONCOLOGY (2018)
Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer
Rajmohan Murali et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Stephanie M. de Boer et al.
LANCET ONCOLOGY (2018)
Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas
David S. Guttery et al.
Oncotarget (2018)
An update of Wnt signalling in endometrial cancer and its potential as a therapeutic target
A. Coopes et al.
ENDOCRINE-RELATED CANCER (2018)
Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial
B. G. Wortman et al.
GYNECOLOGIC ONCOLOGY (2018)
CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
Katherine C. Kurnit et al.
MODERN PATHOLOGY (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Initiation of a formalized precision medicine program in gynecologic oncology
Camille C. Gunderson et al.
GYNECOLOGIC ONCOLOGY (2016)
Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers
Lorna Rodriguez-Rodriguez et al.
GYNECOLOGIC ONCOLOGY (2016)
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer
Janice M. Mehnert et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Disparities in Gynecological Malignancies
Sudeshna Chatterjee et al.
FRONTIERS IN ONCOLOGY (2016)
The mutational landscape of endometrial cancer
Bo Hong et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2015)
Minority participation in Gynecologic Oncology Group (GOG) Studies
Jennifer Scalici et al.
GYNECOLOGIC ONCOLOGY (2015)
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
Update on prognostic markers for endometrial cancer
Pratibha S. Binder et al.
WOMENS HEALTH (2014)
Bokhman's dualistic model of endometrial carcinoma. Revisited
Robert J. Kurman et al.
GYNECOLOGIC ONCOLOGY (2013)
Type I and II Endometrial Cancers: Have They Different Risk Factors?
Veronica Wendy Setiawan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Endometrial carcinoma: molecular alterations involved in tumor development and progression
A. Yeramian et al.
ONCOGENE (2013)
Evolution in Endometrial Cancer Evidence From an Immunohistochemical Study
Ingrid Vandenput et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Racial/ethnic differences in endometrial cancer risk: The multiethnic cohort study
Veronica Wendy Setiawan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
HM Keys et al.
GYNECOLOGIC ONCOLOGY (2004)
分享论文
